GAROFALO, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 284
EU - Europa 160
AS - Asia 109
SA - Sud America 13
AF - Africa 2
Totale 568
Nazione #
US - Stati Uniti d'America 276
IT - Italia 104
SG - Singapore 77
CN - Cina 23
DE - Germania 21
BR - Brasile 11
GB - Regno Unito 10
CA - Canada 7
FI - Finlandia 6
HK - Hong Kong 5
NL - Olanda 5
SE - Svezia 4
RU - Federazione Russa 3
AT - Austria 2
ES - Italia 2
IN - India 2
BD - Bangladesh 1
CL - Cile 1
FR - Francia 1
IQ - Iraq 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
PL - Polonia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 568
Città #
Chandler 48
Singapore 47
Catanzaro 32
Santa Clara 19
Milan 17
Ashburn 16
Munich 16
Lawrence 13
Princeton 13
Chicago 12
Boardman 9
Caserta 9
London 9
Aversa 8
Turku 6
Des Moines 5
Hong Kong 5
Ottawa 5
The Dalles 5
Vallefiorita 5
Wilmington 5
Guangzhou 4
Latina 3
Los Angeles 3
Pescara 3
Redmond 3
Aiello Calabro 2
Assago 2
Beijing 2
Brooklyn 2
Cicciano 2
Cisterna di Latina 2
Cosenza 2
Hanover 2
Nantong 2
Naples 2
New York 2
Rome 2
San Francisco 2
Taranto 2
Amsterdam 1
Augusta 1
Baton Rouge 1
Belo Horizonte 1
Bengbu 1
Boston 1
Casablanca 1
Charlotte 1
Christchurch 1
Clearwater 1
Columbus 1
Concord 1
Dois Irmãos 1
Duhok 1
Fayetteville 1
Fortaleza 1
Franklin Square 1
Goiânia 1
Jinhua 1
Johannesburg 1
Marília 1
Mexico City 1
Moscow 1
Mountain View 1
New Delhi 1
Norfolk 1
Norwalk 1
Novokuznetsk 1
Palermo 1
Papagaios 1
Peruíbe 1
Phoenix 1
Piano di Sorrento 1
Potomac 1
Puerto Cabello 1
Pune 1
Redwood City 1
Rockville 1
Salvador 1
San Jose 1
Seattle 1
Secaucus 1
Shanghai 1
São Gonçalo 1
São Paulo 1
Taizhou 1
Teresina 1
Toronto 1
Tula 1
Wuhan 1
Xuzhou 1
Totale 399
Nome #
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition. 46
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway. 46
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors 44
NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma 44
An Observational Study on Chronic Pain Biomarkers in Fibromyalgia and Osteoarthritis Patients: Which Role for Mu Opioid Receptor's Expression on NK Cells? 40
T-cell immunity against Severe Acute Respiratory Syndrome Coronavirus 2 proteins in patients with type 1 diabetes 39
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy. 36
A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells. 34
NK cells control breast cancer and related cancer stem cell hematological spread 29
Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. 29
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. 28
Helper Innate Lymphoid Cells-Unappreciated Players in Melanoma Therapy 27
Different Insight into Amphiphilic PEG-PLA Copolymers: Influence of Macromolecular Architecture on the Micelle Formation and Cellular Uptake. 27
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. 27
Human NK Cell Subsets in Pregnancy and Disease: Toward a New Biological Complexity. 25
Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis 20
IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients 18
New avenues for melanoma immunotherapy: Natural Killer cells? 11
Exploring the effects of paclitaxel-loaded zein nanoparticles on human ovarian carcinoma cells 11
Role of the androgen receptor in melanoma aggressiveness 11
Totale 592
Categoria #
all - tutte 7.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.146


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 1 0 28 7 0 0
2021/202236 0 0 1 4 0 0 1 7 5 9 9 0
2022/2023140 27 4 3 18 11 16 0 10 26 6 12 7
2023/2024108 18 8 5 10 8 16 11 6 0 2 13 11
2024/2025243 28 15 11 3 14 31 12 11 26 9 37 46
2025/202618 18 0 0 0 0 0 0 0 0 0 0 0
Totale 592